Tongxinluo Improve High on Clopidogrel Platelet Reactivity Patients With Coronary Heart Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.
Also called NCT01721590
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 134 participants
- Sponsor
- Han Yaling
- Registry
-
NCT01721590
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01721590. Randomized; double masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2013-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tongxinluo Improve High on Clopidogrel Platelet Reactivity Patients With Coronary Heart Disease
- Acronym
- Talent
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Tongxinluo
- Intervention (Drug)
- placebo
- Lead sponsor
- Han Yaling
Record details
- Record id
cardio:ct-nct01721590- Content hash
5792194737a4a03d98a4ea8075ffe4c8654606068934096178d295f717e5cb42